SmartNuclide

Technology

Focus on developing the most innovative radiopharmaceuticals

RadiopharmaceuticalsSRCArticles

Immuno-PET imaging of PD-L1 expression in patient-derived lung cancer xenografts with [68Ga]Ga-NOTA-Nb10906/02/2022

Immuno-PET imaging of PD-L1 expression in patient-deriv […]

PET Imaging of Tumor PD-L1 Expression with a Highly Specific Nonblocking Single-Domain Antibody06/02/2022

PET Imaging of Tumor PD-L1 Expression with a Highly Spe […]

Phase I Study of 99mTc-ADAPT6, a Scaffold Protein–Based Probe for Visualization of HER2 Expression in Breast Cancer06/02/2022

Phase I Study of 99mTc-ADAPT6, a Scaffold Protein–Based […]

ImmunoPET imaging of human CD8+ T cells with novel 68Ga‑labeled nanobody companion diagnostic agents05/30/2022

ImmunoPET imaging of human CD8+ T cells with novel 68Ga […]

PET imaging of tumor PD-L1 expression with a highly specific non-blocking nanobody04/30/2022

PET imaging of tumor PD-L1 expression with a highly spe […]

Immuno-PET imaging of 68Ga-labeled nanobody Nb109 for dynamic monitoring the PD-L1 expression in cancers04/30/2022

Immuno-PET imaging of 6868Ga-labeled nanobody Nb109 for […]

Evaluation of SNA001, a Novel Recombinant Human Thyroid Stimulating Hormone Injection, in Patients With Differentiated Thyroid Carcinoma04/30/2022

Evaluation of SNA001, a Novel Recombinant Human Thyroid […]

Lipidomic Perturbations in Cynomolgus Monkeys are Regulated by Thyroid Stimulating Hormone04/30/2022

Lipidomic Perturbations in Cynomolgus Monkeys are Regul […]

A preclinical study: correlation between PD-L1 PET imaging and the prediction of therapy efficacy of MC38 tumor with 68Ga-labeled PD-L1 targeted nanobody04/30/2022

PET imaging of tumor PD-L1 expression with a highly specific non-blocking nanobody